http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019076434-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5bc5292a07e34d16eb1d033a16d3aec3 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate | 2016-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0b0b5613ad2cb68866532de86f2d7d4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7a95eee329cd161aa9bf3f1e89ee7dd |
| publicationDate | 2019-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2019076434-A1 |
| titleOfInvention | Methods of treating peripheral vascular diseases, including systemic sclerosis vasculopathy |
| abstract | Methods for treating diseases in which patients exhibit a reduced exercise capacity due to a decrease in their peripheral blood flow are provided, comprising administering an effective amount of tetrahydrobiopterin to the patient. The patient's resting blood flow is not affected by the administration, and smooth muscle dilating drugs may be administered to the patient concurrently with the tetrahydrobiopterin. Such diseases include chronic heart failure, peripheral vascular disease, diabetes and systemic sclerosis. |
| priorityDate | 2016-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 45.